Skip to main content
. Author manuscript; available in PMC: 2024 Apr 17.
Published in final edited form as: Am J Prev Med. 2015 Aug;49(2 Suppl 1):S6–S13. doi: 10.1016/j.amepre.2015.02.023

Table 1.

Checklist of Family Planning and Related Preventive Health Services for Women

Screening components Family planning services (provide services in accordance with the appropriate clinical recommendation) Related preventive health services
Contraceptive servicesa Pregnancy testing and counseling Basic infertility services Preconception health services STD servicesb
History
 Reproductive life planc Screen Screen Screen Screen Screen
 Medical historyc,d Screen Screen Screen Screen Screen Screen
 Current pregnancy statusc Screen
 Sexual health assessmentc,d Screen Screen Screen Screen
 Intimate partner violencec,d,e Screen
 Alcohol and other drug usec,d,e Screen
 Tobacco usec,e Screen (combined hormonal methods for clients aged ≥35 years) Screen
 Immunizationsc Screen Screen for HPV and HBVf
 Depressionc,e Screen
 Folic acidc,e Screen
Physical examination
 Height, weight, and BMIc,e Screen (hormonal methods)g Screen Screen
 Blood pressurec,e Screen (combined hormonal methods) Screenf
 Clinical breast examd Screen Screenf
 Pelvic examc,d Screen (initiating diaphragm or IUD) Screen (if clinically indicated) Screen
 Signs of androgen excessd Screen
 Thyroid examd Screen
Laboratory testing
 Pregnancy testd Screen (if clinically indicated) Screen
 Chlamydiac,e Screenh Screenf
 Gonorrheac,e Screenh Screenf
 Syphilisc,e Screenf
 HIV/AIDSc,e Screenf
 Hepatitis Cc,e Screenf
 Diabetesc,e Screenf
 Cervical cytologye Screenf
 Mammographye Screen f
a

This table presents highlights from CDC’s recommendations on contraceptive use. However, providers should consult the following guidelines when treating individual patients to obtain more detailed information about specific medical conditions and characteristics (Source: CDC. U.S. medical eligibility criteria for contraceptive use 2010. MMWR. 2010;59 [No.RR-4]).

b

STD services also promote preconception health, but are listed separately here to highlight their importance in the context of all types of family planning visits. The services listed in this column are for women without symptoms suggestive of an STD.

c

CDC recommendation.

d

Professional medical organization recommendation.

e

U.S. Preventive Services Task Force recommendation.

f

Indicates that screening is suggested only for those persons at highest risk or for a specific subpopulation with high prevalence of an infection or condition.

g

Weight (BMI) measurement is not needed to determine medical eligibility for any methods of contraception because all methods can be used (U.S. Medical Eligibility Criteria 1) or generally can be used (U.S. Medical Eligibility Criteria 2) among obese women (Source: CDC. U.S. medical eligibility criteria for contraceptive use 2010. MMWR. 2010;59 [No. 4]). However, measuring weight and calculating BMI at baseline might be helpful for monitoring any changes and counseling women who might be concerned about weight change perceived to be associated with their contraceptive method.

h

Most women do not require additional STD screening at the time of IUD insertion if they have already been screened according to CDC’s STD treatment guidelines (Source: CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR. 2010;59 [RR-12]. www.cdc.gov/std/treatment/). If a woman has not been screened according to guidelines, screening can be performed at the time of IUD insertion, and insertion should not be delayed. Women with purulent cervicitis or current chlamydial infection or gonorrhea should not undergo IUD insertion (U.S. Medical Eligibility Criteria 4), and women who have a very high individual likelihood of STI exposure (e.g., those with a currently infected partner) generally should not undergo IUD insertion (U.S. Medical Eligibility Criteria 3) (Source: CDC. U.S. medical eligibility criteria for contraceptive use 2010. MMWR Recomm Rep. 2010;59[RR-4]). For these women, IUD insertion should be delayed until appropriate testing and treatment occurs.

HBV, hepatitis B virus; HPV, human papillomavirus; IUD, intrauterine device; STD, sexually transmitted disease; STI, sexually transmitted infection.